carcinoembryonic antigen

(redirected from Cancer Antigens)
Also found in: Medical, Encyclopedia.
Related to Cancer Antigens: CA125 ovarian cancer antigen

car·ci·no·em·bry·on·ic antigen

 (kär′sə-nō-ĕm′brē-ŏn′ĭk)
n. Abbr. CEA
A glycoprotein present in fetal gastrointestinal tissue and in the cells or serum of adults having certain cancers. It is used clinically to monitor the effectiveness of a treatment, as for colorectal cancer.
Mentioned in ?
References in periodicals archive ?
Finding a way to selectively induce tolerance to donor antigens, while maintaining immunity to pathogens and cancer antigens would represent a major breakthrough in medicine with the achievement of immunosuppression-free organ transplantation.
immatics' unique and world-leading technology platform XPRESIDENT discovers novel relevant cancer antigens known to be expressed on tumor cells.
The XPRESIDENT discovery platform is to date the only known high-throughput research technology to directly identify, quantify, and prioritize cancer antigens recognized by T lymphocytes (type of white blood cell) based on the ability of the immune system to detect them.
These highly relevant peptide cancer antigens constitute the basis for developing a range of rationally designed cancer immunotherapies including cancer vaccines, peptide-targeting compounds such as antibodies, soluble T-cell receptors and adoptive cellular therapies.
These relevant peptide cancer antigens constitute the basis for developing a range of rationally designed cancer immunotherapies including cancer vaccines, peptide-targeting compounds such as antibodies, soluble T-cell receptors and adoptive cellular therapies.
ImmunoCellular's pipeline also includes ICT-121, a dendritic cell vaccine targeting CD133, and ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells.
A significant body of literature reports the presence of autoantibodies against cancer antigens in the peripheral circulation of cancer patients--shown to be true in lung, breast, cervical, and colorectal cancers, among others.
We fight cancer with immunotherapy by creating antibodies against cancer antigens.
This meant that the immune system 'self-selected' the cancer antigens to respond to and did not react against other healthy parts of the body.
co-director of University of Pennsylvania's Rena Rowan Breast Cancer Center and Surgical Director of the immunotherapy program at the Abramson Cancer Center, the technology enables the development of DCs designed to trigger powerful and targeted immune responses to specific cancer antigens.
The CDMRP funds will be used to engineer Listeria strains to express a combination of tumor-associated prostate cancer antigens, which reduces the likelihood of the tumor escaping the immune response and increases the likelihood of a broader and more effective immune response.
DCOne-based dendritic cell vaccines, in some indications loaded with cancer antigens for targeted treatment, are used as standardized, therapeutic products.